Experimental Sciences
Biophysical characteristics of genipin-crosslinked amniotic membrane bio-scaffold
Yanfeng Yin, Liu Yang, Qiufen Tu, Sha Lyu, Zheng Guan, Wenjun Su, Yunchuan Li, Lan Li
Published 2018-02-10
Cite as Chin J Exp Ophthalmol, 2018, 36(2): 107-112. DOI: 10.3760/cma.j.issn.2095-0160.2018.02.007
Abstract
ObjectiveTo investigate the characteristics and feasibility of genipin-crosslinked amniotic membrane(AM) as bio-scaffold.
MethodsHuman umbilical cord mesenchymal stem cells (hUCMSCs) were isolated from fresh umbilical cord and cultured by adherent method.The expressions of PE-CD34, PE-CD45, PE-CD90, FITC-105 and FITC-Oct-4, the markers of hUCMSCs, were detected by flow cytometry.Alizarin red and oil red O staining were performed to identify the cells after adipogenesis and osteogenesis induction on the third-generation cells.Human AMs were treated at 37 ℃ and 45 ℃ by 0.5% and 1% genipin solution for 24, 36 and 48 hours respectively, and the mechanical properties of AM in each group were measured and compared.The hUCMSCs were divided into only hUCMSCs culture group, fresh AM group, crosslinked AM group, gelatin group and crosslinked AM+ gelatin group, and the cells were cultured in the corresponding medium.The content of hydroxyproline among the groups was detected with hydroxyproline kit, and proliferation of the cells (absorbance) was assayed by MTT method to evaluate the biological compatibility of crosslinked AM.
ResultsThe maximum tensile displacement of the crosslinked-AM by 0.5% and 1% genipin was (8.31±0.43)mm and (4.49±0.37)mm respectively, and those after crosslinked with 0.5% genipin under the 37 ℃ and 45 ℃ for 24 hours was (9.89±1.09)mm and (5.39±0.59)mm, respectively, showing a significant difference between them (t=6.389, P<0.05). The maximum tensile displacement of the crosslinked-AM was gradually decreased as the lapse of crosslinking time, and an insignificant difference was found among 24, 36 and 48 hours after 0.5% genipin treatment under the 37 ℃ (P>0.05). The loading force of the crosslinked-AM was significantly higher in the 1% genipin treated group than that in the 0.5% genipin treated group (P<0.05), and the loading force of the AM was significantly increased in 45 ℃, 0.5% genipin, 24 hours crosslinked group compared with the 37 ℃, 0.5% genipin, 24 hours crosslinked group (t=5.528, P<0.05). The content of hydroxyproline in the AM was (1.28±0.36), (2.03±0.49) and (2.11±0.10)mg/g in the 1% genipin crosslinked AM group, 0.5% genipin crosslinked AM group and fresh AM group, respectively, and the content of hydroxyproline in the AM in the 1 % genipin group was significantly lower than that in the 0.5% genipin group in the fresh AM group (both at P<0.05). The proliferative values of the hUCMSCs were significantly lower in the only hUCMSCs culture group, fresh AM group and gelatin group were significantly reduced in comparison with the crosslinked AM group and crosslinked AM+ gelatin group (all at P<0.05). There was no significant difference in the proliferative values of the hUCMSCs between crosslinked AM group and crosslinked AM+ gelatin group (P>0.05).
ConclusionsDifferent crosslinked temprature, crosslinking period and concentration of genipin impact the mechanical properties of AM.Crosslinked AM with genipin is feasible as a carrier scaffold of artificial cornea because of less tissue toxicity and better plasticity.
Key words:
Amniotic membrane; Cross-linking reagents/pharmacology; Stress, mechanical; Tensile strength; Umbilical cord mesenchymal stem cells; Biological compatibility; Genipin
Contributor Information
Yanfeng Yin
The Central Laboratory, The First Hospital of Kunming, Affiliated Calmette Hospital of Kunming Medical University, Kunming 650011, China
Liu Yang
The Central Laboratory, The First Hospital of Kunming, Affiliated Calmette Hospital of Kunming Medical University, Kunming 650011, China
Qiufen Tu
Department of Actuarial-Oriented, School of Materials Science and Engineering, Southwest Jiao Tong University, Chengdu 610031, China
Sha Lyu
The Central Laboratory, The First Hospital of Kunming, Affiliated Calmette Hospital of Kunming Medical University, Kunming 650011, China
Zheng Guan
The Central Laboratory, The First Hospital of Kunming, Affiliated Calmette Hospital of Kunming Medical University, Kunming 650011, China
Wenjun Su
The Central Laboratory, The First Hospital of Kunming, Affiliated Calmette Hospital of Kunming Medical University, Kunming 650011, China
Yunchuan Li
Department of Ophthalmology, The First Hospital of Kunming, Affiliated Calmette Hospital of Kunming Medical University, Kunming 650011, China
Lan Li
Department of Ophthalmology, The First Hospital of Kunming, Affiliated Calmette Hospital of Kunming Medical University, Kunming 650011, China